找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

SCIE期刊CARDIOVASCULAR DRUGS AND THERAPY 2024/2025影响因子:3.146 (CARDIOVASC DRUG THER) (0920-3206). (PHARMACOLOGY & PHARMACY

[复制链接]
楼主: Goiter
发表于 2025-3-26 21:27:28 | 显示全部楼层
发表于 2025-3-27 03:23:07 | 显示全部楼层
Submitted on: 24 June 2022. Revised on: 19 October 2022. Accepted on: 12 November 2022. ___________________CARDIOVASCULAR DRUGS AND THERAPY
发表于 2025-3-27 06:55:04 | 显示全部楼层
Submitted on: 15 April 2013. Revised on: 23 May 2013. Accepted on: 19 July 2013. ___________________CARDIOVASCULAR DRUGS AND THERAPY
发表于 2025-3-27 12:44:02 | 显示全部楼层
Submitted on: 12 December 2010. Revised on: 09 January 2011. Accepted on: 23 February 2011. ___________________CARDIOVASCULAR DRUGS AND THERAPY
发表于 2025-3-27 13:55:34 | 显示全部楼层
Submitted on: 17 November 2003. Revised on: 13 January 2004. Accepted on: 17 February 2004. ___________________CARDIOVASCULAR DRUGS AND THERAPY
发表于 2025-3-27 18:56:26 | 显示全部楼层
Submitted on: 20 July 2012. Revised on: 24 October 2012. Accepted on: 05 December 2012. ___________________CARDIOVASCULAR DRUGS AND THERAPY
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-1 16:15
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表